Previous close | 55.79 |
Open | 55.91 |
Bid | 54.01 x 900 |
Ask | 0.00 x 800 |
Day's range | 54.87 - 56.34 |
52-week range | 52.82 - 74.00 |
Volume | |
Avg. volume | 1,170,681 |
Market cap | 15.861B |
Beta (5Y monthly) | 0.75 |
PE ratio (TTM) | 22.96 |
EPS (TTM) | 2.39 |
Earnings date | 24 Apr 2023 - 28 Apr 2023 |
Forward dividend & yield | 0.46 (0.85%) |
Ex-dividend date | 02 Feb 2023 |
1y target est | 65.10 |
U.S. stock markets are going through an unusually volatile period, thanks to the uncertainty posed by the global banking crisis and the Federal Reserve's plan for interest rates. While wild price swings can be nerve-racking for shareholders, choppy markets can also be a great time to pick up shares of top companies at significant discounts to their intrinsic value. Which growth stocks are on watch for a possible entry point?
PillarRx, a leading provider of pharmacy consulting, auditing, and copay assistance services, today announced the PillarRx developed proprietary application platforms AccuCAST, Client Management, Copay (FMH) API, Insight, and PAX have earned Certified status for information security by HITRUST.
Brown & Brown (BRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.